S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
BAC   42.14 (+1.08%)
ETR:SHL

Siemens Healthineers Price Target, Predictions & Analyst Ratings

€59.54
+0.70 (+1.19 %)
(As of 09/23/2021 12:00 AM ET)
Add
Compare
Today's Range
€58.92
€59.86
50-Day Range
€53.34
€61.00
52-Week Range
€36.16
€61.50
Volume469,023 shs
Average VolumeN/A
Market Capitalization$67.11 billion
P/E Ratio37.73
Dividend Yield1.36%
BetaN/A

Siemens Healthineers (ETR:SHL) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 13 Analyst Ratings

Analyst Price Target Consensus

€54.20

High PT€64.00
Average PT€54.20
Low PT€42.00
TypeCurrent
9/24/20 to 9/24/21
1 Month Ago
8/25/20 to 8/25/21
3 Months Ago
6/26/20 to 6/26/21
1 Year Ago
9/25/19 to 9/24/20
Consensus Rating
Buy
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
7 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price Target€54.20€52.80€51.57€42.64
Get Siemens Healthineers Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SHL and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Siemens Healthineers (ETR:SHL) vs. Its Competitors

TypeSiemens HealthineersMedical Companies
Consensus Rating Score
2.62
2.73
Consensus RatingBuyBuy
News Sentiment RatingNeutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
221
57.40%
Underperform Votes
164
42.60%
Avg. Outperform Votes
178
67.42%
Avg. Underperform Votes
86
32.58%

Siemens Healthineers (ETR:SHL) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/24/2021JPMorgan Chase & Co.
Adlington David
Set Price Target€58.70-1.41%
9/20/2021Jefferies Financial Group
Vane-Tempes... James
Set Price Target€53.00+530,000,000.00%
9/14/2021Berenberg Bank
Bardo Scott
Set Price Target€64.00+15.15%
9/10/2021Barclays
Al-Wakeel Hassan
Set Price Target€55.00-4.01%
9/2/2021Nord/LB
Fechner Holger
Set Price Target€60.00+0.57%
8/3/2021Credit Suisse Group
Yates Max
Set Price Target€60.00+6.04%
8/2/2021Kepler Capital Markets
Mackie William
Set Price Target€57.50+3.27%
7/14/2021Morgan Stanley
Jüngling Michael
Set Price Target€46.40-14.07%
6/25/2021DZ Bank
Reiterated RatingNeutral
6/14/2021UBS Group
Set Price TargetNeutral€48.00-0.64%
5/4/2021Independent Research
Set Price TargetNeutral€51.00+5.33%
5/4/2021Deutsche Bank Aktiengesellschaft
Set Price TargetBuy€56.00+15.65%
2/3/2021Sanford C. Bernstein
Set Price TargetBuy€53.00+10.15%
1/26/2021Royal Bank of Canada
Set Price TargetNeutral€42.00-4.11%
6/1/2020The Goldman Sachs Group
Set Price TargetNeutral€32.00-31.13%
11/18/2019HSBC
Set Price TargetNeutral€42.00-3.50%
11/4/2019Commerzbank
Set Price TargetBuy€45.00+11.58%
11/5/2018equinet
Set Price TargetNeutral€39.00+4.14%
9/27/2018Citigroup
Set Price TargetBuy€42.50+11.74%
(Data available from 9/24/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles











Siemens Healthineers (ETR:SHL) Analyst Ratings Frequently Asked Questions

What is Siemens Healthineers's consensus rating and price target?

According to the issued ratings of 13 analysts in the last year, the consensus rating for Siemens Healthineers stock is Buy based on the current 5 hold ratings and 8 buy ratings for SHL. The average twelve-month price target for Siemens Healthineers is €54.20 with a high price target of €64.00 and a low price target of €42.00. Learn more on SHL's analyst rating history

Do Wall Street analysts like Siemens Healthineers more than its competitors?

Analysts like Siemens Healthineers stock less than the stock of other Medical companies. The consensus rating score for Siemens Healthineers is 2.62 while the average consensus rating score for medical companies is 2.73. Learn more on how SHL compares to other companies

Do MarketBeat users like Siemens Healthineers more than its competitors?

MarketBeat users like Siemens Healthineers stock less than the stock of other Medical companies. 57.40% of MarketBeat users gave Siemens Healthineers an outperform vote while medical companies recieve an average of 67.42% outperform votes by MarketBeat users.

Does Siemens Healthineers's stock price have much upside?

According to analysts, Siemens Healthineers's stock has a predicted upside of 7.83% based on their 12-month price targets.

What analysts cover Siemens Healthineers?

This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.